RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. SymBiosis
S

SymBiosis portfolio

SymBiosis has 6 portfolio companies on record at Recent Funding, with 4 investments in the last 12 months.

Website: symbiosis.vc.
Type: Venture capital.
Portfolio on Recent Funding: 6.
Deals, last 12 months: 4.
Rounds led: 1 of 7.
Capital in their rounds: $908.9M.
Latest deal: AdvanCell · Jul 15, 2026.
About this page

It is a venture capital firm based in Bentonville, US, founded in 2021. It led 1 of the 7 rounds it joined. Its most recent investment on record is AdvanCell's $315M Series B+ round in July 2026, alongside Fidelity Management & Research Company, Morningside, Eli Lilly and 15 others. By category, its portfolio leans toward Health and bio (6) and Manufacturing and industrial (1). It has co-invested with Abingworth, Sanofi Ventures and Morningside, most often Abingworth (3 rounds).

About SymBiosis

Firm type: Venture capital.
Headquarters: Bentonville, US.
Founded: 2021.
Stages: Seed, Series A, Series B, Series C, Late Stage.
Sectors: Biotech.

What SymBiosis invests in

SymBiosis recent investments

How SymBiosis invests

StageDealsCapital in rounds
Series B+ 6 86%$831.4M
Series A 1 14%$77.5M
YearDealsCapital in rounds
2021 1 14%undisclosed
2023 1 14%$50M
2025 1 14%$112M
2026 4 57%$746.9M

SymBiosis portfolio companies

CompanyRound with SymBiosisTotal raisedLatest raise
AAdvanCell
Health and bio
Series B+ · $315M$439.5MJul 15, 2026
Series B+
FFore Biotherapeutics
Health and bio
Series B+ · $67.4M$182.4MJul 8, 2026
Series B+
RR1 Therapeutics
Health and bio
Series A · $77.5M$158MSep 30, 2026
Series A
CCorxel
Health and bio
Series B+ · $287M$287MJan 26, 2026
Series B+
EEnsoma
Health and bio
Series B+ · $50M$50MMay 16, 2023
Series B+
VVedanta Biosciences
Health and bio
Series B+$166.5MAug 6, 2026
round

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 7 rounds on Recent Funding that name SymBiosis. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists SymBiosis, which is a subset of its real portfolio. API: /api/v1/investors/symbiosis (get a free API key). More: the most active VC firms and new venture capital funds.

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy